The groundbreaking rise of Viagra has long been a symbol of pharmaceutical success, yet its position within the broader industry now raises questions about potential returns . Alternative versions are undercutting exclusivity , causing worries that betting on companies closely tied to Viagra's former position could be a problematic decision , espec